Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
phosphomannopentaose sulfate
×
Clear all
Filters
2
NCT01402908
2022-06-23
PATRON
Cellxpert Biotechnology Corp.
Phase 3
Terminated
520 enrolled
27 charts
NCT00568308
2011-06-15
PATHWAY
Progen Pharmaceuticals
Phase 3
Terminated
600 enrolled